Hormonal intrauterine device (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hormonal intrauterine device" in English language version.

refsWebsite
Global rank English rank
4th place
4th place
1st place
1st place
2nd place
2nd place
11th place
8th place
102nd place
76th place
5th place
5th place
low place
low place
447th place
338th place
218th place
212th place
low place
low place
3rd place
3rd place
low place
low place
269th place
201st place
low place
low place
low place
6,693rd place
195th place
302nd place
low place
low place
399th place
333rd place
3,984th place
2,622nd place
1,712th place
1,063rd place
3,160th place
2,065th place
low place
low place
1,523rd place
976th place
1,916th place
1,419th place
3,823rd place
2,387th place
4,334th place
4,154th place
18th place
17th place
low place
low place
621st place
380th place
low place
low place
low place
low place
low place
low place
9,781st place
5,538th place
768th place
482nd place
175th place
137th place

aafp.org

abc15.com

bayerresources.com.au

books.google.com

businessfinland.fi

  • Laitinen K. "Bayer". businessfinland.fi. Archived from the original on 21 September 2021. Retrieved 21 September 2021.

canada.ca

health-products.canada.ca

cdc.gov

contraceptivetechnology.org

  • Trussell J (2011). "Contraceptive efficacy". In Hatcher RA, Trussell J, Nelson AL, Cates Jr W, Kowal D, Policar MS (eds.). Contraceptive technology (20th revised ed.). New York: Ardent Media. pp. 779–863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = "Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States" (PDF). Archived from the original (PDF) on 15 February 2017.

ctvnews.ca

doi.org

drugs.com

escholarship.org

fda.gov

accessdata.fda.gov

fda.gov

handle.net

hdl.handle.net

harvard.edu

ui.adsabs.harvard.edu

inchem.org

infoforhealth.org

jaydess.co.uk

medicines.org.uk

  • "Mirena". Bayer UK. 11 June 2013. Archived from the original on 18 June 2015. Retrieved 18 June 2015.

mirena-us.com

hcp.mirena-us.com

mirena-us.com

newsnet5.com

newsweek.com

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

dailymed.nlm.nih.gov

nichd.nih.gov

nihr.ac.uk

journalslibrary.nihr.ac.uk

evidence.nihr.ac.uk

plannedparenthood.org

rexall.ca

  • "Mirena". MediResource Inc. Archived from the original on 3 July 2015. Retrieved 18 June 2015.

semanticscholar.org

api.semanticscholar.org

tga.gov.au

ufba.br

repositorio.ufba.br

vice.com

broadly.vice.com

web.archive.org

who.int

apps.who.int

who.int

worldcat.org

search.worldcat.org

  • Trussell J (2011). "Contraceptive efficacy". In Hatcher RA, Trussell J, Nelson AL, Cates Jr W, Kowal D, Policar MS (eds.). Contraceptive technology (20th revised ed.). New York: Ardent Media. pp. 779–863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = "Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States" (PDF). Archived from the original (PDF) on 15 February 2017.
  • Jensen JT, Creinin MD, Speroff L, eds. (2019). Speroff & Darney's clinical guide for contraception (Sixth ed.). Philadelphia, PA: Wolters Kluwer. p. 15. ISBN 978-1-9751-0728-4. OCLC 1121081247.
  • Oelschlager AM, Debiec K, Micks E, Prager S (2013). "Use of the Levonorgestrel Intrauterine System in Adolescents With Known Uterine Didelphys or Unicornuate Uterus". Journal of Pediatric and Adolescent Gynecology. 26 (2): e58. doi:10.1016/j.jpag.2013.01.029. ISSN 1083-3188.
  • Dean G, Schwarz EB (2011). "Intrauterine contraceptives (IUCs)". In Hatcher RA, Trussell J, Nelson AL, Cates Jr W, Kowal D, Policar MS (eds.). Contraceptive technology (20th revised ed.). New York: Ardent Media. pp. 147–191. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. p.150:

    Mechanism of action
    Although the precise mechanism of action is not known, currently available IUCs work primarily by preventing sperm from fertilizing ova.26 IUCs are not abortifacients: they do not interrupt an implanted pregnancy.27 Pregnancy is prevented by a combination of the "foreign body effect" of the plastic or metal frame and the specific action of the medication (copper or levonorgestrel) that is released. Exposure to a foreign body causes a sterile inflammatory reaction in the intrauterine environment that is toxic to sperm and ova and impairs implantation.28,29 The production of cytotoxic peptides and activation of enzymes lead to inhibition of sperm motility, reduced sperm capacite journal and survival, and increased phagocytosis of sperm.30,31… The progestin in the LNg IUC enhances the contraceptive action of the device by thickening cervical mucus, suppressing the endometrium, and impairing sperm function. In addition, ovulation is often impaired as a result of systemic absorption of levonorgestrel.23
    p. 162:
    Table 7-1. Myths and misconceptions about IUCs
    Myth: IUCs are abortifacients. Fact: IUCs prevent fertilization and are true contraceptives.

wustl.edu

digitalcommons.wustl.edu

zenodo.org